Novofem 1 mg. FC tablet.
PDF Leaflet Revision Date: 26 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of symptoms associated with estrogen deficiency in postmenopausal women.
Dosage (summary)
One tablet daily; red for 16 days, white for 12 days.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Anticonvulsants
- Antibiotics
- St John's wort
- Ciclosporin
- Insulin
Contraindications
- Hypersensitivity
- Breast cancer
- Estrogen-dependent tumors
- Undiagnosed bleeding
- Thromboembolic disorders
- Active liver disease
- Pregnancy
- Lactation
Common side effects
- Breast tenderness
- Headache
- Dizziness
- Nausea
- Weight increase
Counselling Points
- Take at the same time daily
- Report any unusual bleeding
- Regular breast examinations recommended
- Monitor mood changes
Serious warnings
- Increased risk of thromboembolism
- Breast cancer risk
- Endometrial cancer risk
- Possible dementia risk over 65
Important Disclaimer
The Novofem 1 mg. FC tablet. professional information leaflet below is the property of Novo Nordisk and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
